KRAS and pancreatic adenocarcinoma: Consistent with our data, analyzes of pancreatic adenocarcinoma in The Cancer Genome Atlas (TCGA) and Australian Pancreatic Genome Initiative (APGI) revealed that copy number variations of the KRAS gene were only attributed to amplification, with a low incidence38,40.